Table 8. Differentially expressed mRNAs encoding chemokines, interleukins and their receptors in the oviducts of PMSG-treated ESR1KO versus PMSG-treated WT mice.

Overall Model: P < 0.01 and at least a 2-fold change in gene expression.

Gene Symbol	Gene Description	P-value	Fold-Change
Cx3cl1	chemokine (C-X3-C motif) ligand 1	0.004	2.25
Cxcl12	chemokine (C-X-C motif) ligand 12	< 0.001	4.21
Cxcl14	chemokine (C-X-C motif) ligand 14	0.001	-3.31
Cxcl16	chemokine (C-X-C motif) ligand 16	0.011	1.73
Cxcl17	chemokine (C-X-C motif) ligand 17	0.003	3.68
Cxcr4	chemokine (C-X-C motif) receptor 4	0.063	1.61
Cxcr7	chemokine (C-X-C motif) receptor 7	< 0.001	-3.32
Il13ra2	interleukin 13 receptor, alpha 2	0.003	4.48
Il15	interleukin 15	< 0.001	2.70
Il15ra	interleukin 15 receptor, alpha chain	< 0.001	5.16
Il16	interleukin 16	0.002	1.62
Il17ra	interleukin 17 receptor A	< 0.001	-2.25
Il17rb	interleukin 17 receptor B	< 0.001	14.38
Il17re	interleukin 17 receptor E	0.002	3.00
Il18	interleukin 18	0.002	1.82
Il18bp	interleukin 18 binding protein	< 0.001	-20.01
Il18r1	interleukin 18 receptor 1	< 0.001	19.45
Il1r1	interleukin 1 receptor, type I	0.001	2.14
Il1rap	interleukin 1 receptor accessory protein	< 0.001	1.53
Il33	interleukin 33	< 0.001	11.69
Il7	interleukin 7	0.001	3.94
Ilf2	interleukin enhancer binding factor 2	0.012	1.31

Fold-Change in gene expression and P-Values are indicated. Positive changes in fold-change represent increased expression in the oviducts of PMSG-treated ESR1KO mice.